Global Blood Therapeutics Inc. — Sponsor Intelligence | 1 EU Trials

Filter these 1 trials by condition, phase, country and more.

1 Registered trials

0 Recruiting

0 Completed trials

2 Countries active

1 Unique IMPs

N/A Results reported

Phase II/III

Oversight events:

1 corrective measure across 1 trial

Top indications

1 total

A Phase 2/3 Study in Adult and Pediatric Participants with SCD Suspended

2023-508766-14-00 Phase II/III 2 countries (S)-2-HYDROXY-6-((4-(2-(2-HYDROXYETHYL)NICOTINOYL)MORPHOLIN-3-YL)METHOXY)BENZALD…

Showing 1–1 of 1 trials